Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder
- 25 October 2005
- journal article
- Published by Elsevier BV in Psychiatry Research: Neuroimaging
- Vol. 140 (2), 133-145
- https://doi.org/10.1016/j.pscychresns.2005.07.004
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- Overt Aggression and Psychotic Symptoms in Patients With Schizophrenia Treated With Clozapine, Olanzapine, Risperidone, or HaloperidolJournal of Clinical Psychopharmacology, 2004
- Adjunctive Divalproex and Hostility Among Patients With Schizophrenia Receiving Olanzapine or RisperidonePsychiatric Services, 2004
- The Relationship of Clozapine and Haloperidol Treatment Response to Prefrontal, Hippocampal, and Caudate Brain VolumesAmerican Journal of Psychiatry, 2003
- Neurocognitive Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol in Patients With Chronic Schizophrenia or Schizoaffective DisorderAmerican Journal of Psychiatry, 2002
- Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective DisorderAmerican Journal of Psychiatry, 2002
- An MRI Study of Basal Ganglia Volumes in First-Episode Schizophrenia Patients Treated With RisperidoneAmerican Journal of Psychiatry, 2001
- Reduction of frontal neocortical grey matter associated with affective aggression in patients with temporal lobe epilepsy: an objective voxel by voxel analysis of automatically segmented MRIJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Investigation of frontal lobe subregions in first-episode schizophreniaPsychiatry Research: Neuroimaging, 1999
- Insensitivity to future consequences following damage to human prefrontal cortexCognition, 1994
- Synaptic rearrangements in medial prefrontal cortex of haloperidol-treated ratsBrain Research, 1985